Clinical trials: Phototype
Acne Vulgaris
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
This is a multicenter open-label, prospective study in subjects with dark skin from one of the 3 ethnic/race backgrounds: Asian, Latin American and Black/African-American and with moderate to severe acne vulgaris on the face.
- Trial name
- EDeN (NCT02932267)
- Testing
- Adapalene 0.3% / BPO 2.5% gel
- Where
- 3 sites in United States, Mauritius and 1 more
- Volunteers
- 50 people
- Sponsor
- Galderma R&D